Industry: Healthcare
Published Date: June-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 219
Report ID: PMRREP34582
1. Executive Summary
1.1. Global Radiopharmaceutical Manufacturing Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Technology Assessment
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.4.1. List of Distribution Channel/Marketplaces
3.4.1.1. Retail
3.4.1.2. Audiology
3.4.1.3. E-Commerce
3.4.2. List of End User (Industry)
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter's Five Force Analysis
4. Global Radiopharmaceutical Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
4.3. Global Radiopharmaceutical Manufacturing Market Outlook: Type of Radioisotope
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Type of Radioisotope, 2018 - 2023
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Radioisotope, 2024 - 2031
4.3.3.1. Technetium-99m
4.3.3.2. Fluorine-18
4.3.3.3. Leutetium-177
4.3.3.4. Gallium-68
4.3.3.5. Yttrium-90
4.3.3.6. Other Radioisotopes
4.4. Market Attractiveness Analysis: Type of Radioisotope
4.5. Global Radiopharmaceutical Manufacturing Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2018 - 2023
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024 - 2031
4.5.3.1. Oncology
4.5.3.2. Gastroenterology
4.5.3.3. Cardiology
4.5.3.4. Neuroendocrinology
4.5.3.5. Neurology
4.5.3.6. Nephrology
4.5.3.7. Others
4.6. Market Attractiveness Analysis: Application
4.7. Global Radiopharmaceutical Manufacturing Market Outlook: Source
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis, By Source, 2018 - 2023
4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2024 - 2031
4.7.3.1. Cyclotrons
4.7.3.2. Nuclear Reactors
4.8. Market Attractiveness Analysis: Source
4.9. Global Radiopharmaceutical Manufacturing Market Outlook: End-use
4.9.1. Introduction / Key Findings
4.9.2. Historical Market Size (US$ Mn) Analysis, By End-use, 2018 - 2023
4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2024 - 2031
4.9.3.1. Hospitals
4.9.3.2. Diagnostic Imaging Centers
4.9.3.3. Ambulatory Surgical Centers
4.9.3.4. Cancer Research Institute
4.10. Market Attractiveness Analysis: End-use
5. Global Radiopharmaceutical Manufacturing Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2023
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Radiopharmaceutical Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2023
6.3.1. By Country
6.3.2. By Type of Radioisotope
6.3.3. By Application
6.3.4. By Source
6.3.5. By End-use
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2031
6.4.1. U.S.
6.4.2. Canada
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Radioisotope, 2024 - 2031
6.5.1. Technetium-99m
6.5.2. Fluorine-18
6.5.3. Leutetium-177
6.5.4. Gallium-68
6.5.5. Yttrium-90
6.5.6. Other Radioisotopes
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024 - 2031
6.6.1. Oncology
6.6.2. Gastroenterology
6.6.3. Cardiology
6.6.4. Neuroendocrinology
6.6.5. Neurology
6.6.6. Nephrology
6.6.7. Others
6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2024 - 2031
6.7.1. Cyclotrons
6.7.2. Nuclear Reactors
6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2024 - 2031
6.8.1. Hospitals
6.8.2. Diagnostic Imaging Centers
6.8.3. Ambulatory Surgical Centers
6.8.4. Cancer Research Institute
6.9. Market Attractiveness Analysis
7. Europe Radiopharmaceutical Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2023
7.3.1. By Country
7.3.2. By Type of Radioisotope
7.3.3. By Application
7.3.4. By Source
7.3.5. By End-use
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2031
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Türkiye
7.4.8. Rest of Europe
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Radioisotope, 2024 - 2031
7.5.1. Technetium-99m
7.5.2. Fluorine-18
7.5.3. Leutetium-177
7.5.4. Gallium-68
7.5.5. Yttrium-90
7.5.6. Other Radioisotopes
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024 - 2031
7.6.1. Oncology
7.6.2. Gastroenterology
7.6.3. Cardiology
7.6.4. Neuroendocrinology
7.6.5. Neurology
7.6.6. Nephrology
7.6.7. Others
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2024 - 2031
7.7.1. Cyclotrons
7.7.2. Nuclear Reactors
7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2024 - 2031
7.8.1. Hospitals
7.8.2. Diagnostic Imaging Centers
7.8.3. Ambulatory Surgical Centers
7.8.4. Cancer Research Institute
7.9. Market Attractiveness Analysis
8. East Asia Radiopharmaceutical Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2023
8.3.1. By Country
8.3.2. By Type of Radioisotope
8.3.3. By Application
8.3.4. By Source
8.3.5. By End-use
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2031
8.4.1. China
8.4.2. Japan
8.4.3. South Korea
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Radioisotope, 2024 - 2031
8.5.1. Technetium-99m
8.5.2. Fluorine-18
8.5.3. Leutetium-177
8.5.4. Gallium-68
8.5.5. Yttrium-90
8.5.6. Other Radioisotopes
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024 - 2031
8.6.1. Oncology
8.6.2. Gastroenterology
8.6.3. Cardiology
8.6.4. Neuroendocrinology
8.6.5. Neurology
8.6.6. Nephrology
8.6.7. Others
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2024 - 2031
8.7.1. Cyclotrons
8.7.2. Nuclear Reactors
8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2024 - 2031
8.8.1. Hospitals
8.8.2. Diagnostic Imaging Centers
8.8.3. Ambulatory Surgical Centers
8.8.4. Cancer Research Institute
8.9. Market Attractiveness Analysis
9. South Asia and Oceania Radiopharmaceutical Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2023
9.3.1. By Country
9.3.2. By Type of Radioisotope
9.3.3. By Application
9.3.4. By Source
9.3.5. By End-use
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2031
9.4.1. India
9.4.2. Southeast Asia
9.4.3. ANZ
9.4.4. Rest of South Asia & Oceania
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Radioisotope, 2024 - 2031
9.5.1. Technetium-99m
9.5.2. Fluorine-18
9.5.3. Leutetium-177
9.5.4. Gallium-68
9.5.5. Yttrium-90
9.5.6. Other Radioisotopes
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024 - 2031
9.6.1. Oncology
9.6.2. Gastroenterology
9.6.3. Cardiology
9.6.4. Neuroendocrinology
9.6.5. Neurology
9.6.6. Nephrology
9.6.7. Others
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2024 - 2031
9.7.1. Cyclotrons
9.7.2. Nuclear Reactors
9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2024 - 2031
9.8.1. Hospitals
9.8.2. Diagnostic Imaging Centers
9.8.3. Ambulatory Surgical Centers
9.8.4. Cancer Research Institute
9.9. Market Attractiveness Analysis
10. North America Radiopharmaceutical Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2023
10.3.1. By Country
10.3.2. By Type of Radioisotope
10.3.3. By Application
10.3.4. By Source
10.3.5. By End-use
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2031
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Radioisotope, 2024 - 2031
10.5.1. Technetium-99m
10.5.2. Fluorine-18
10.5.3. Leutetium-177
10.5.4. Gallium-68
10.5.5. Yttrium-90
10.5.6. Other Radioisotopes
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024 - 2031
10.6.1. Oncology
10.6.2. Gastroenterology
10.6.3. Cardiology
10.6.4. Neuroendocrinology
10.6.5. Neurology
10.6.6. Nephrology
10.6.7. Others
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2024 - 2031
10.7.1. Cyclotrons
10.7.2. Nuclear Reactors
10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2024 - 2031
10.8.1. Hospitals
10.8.2. Diagnostic Imaging Centers
10.8.3. Ambulatory Surgical Centers
10.8.4. Cancer Research Institute
10.9. Market Attractiveness Analysis
11. Middle East & Africa Radiopharmaceutical Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2023
11.3.1. By Country
11.3.2. By Type of Radioisotope
11.3.3. By Application
11.3.4. By Source
11.3.5. By End-use
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2031
11.4.1. GCC Countries
11.4.2. Egypt
11.4.3. South Africa
11.4.4. Northern Africa
11.4.5. Rest of Middle East & Africa
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Radioisotope, 2024 - 2031
11.5.1. Technetium-99m
11.5.2. Fluorine-18
11.5.3. Leutetium-177
11.5.4. Gallium-68
11.5.5. Yttrium-90
11.5.6. Other Radioisotopes
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024 - 2031
11.6.1. Oncology
11.6.2. Gastroenterology
11.6.3. Cardiology
11.6.4. Neuroendocrinology
11.6.5. Neurology
11.6.6. Nephrology
11.6.7. Others
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2024 - 2031
11.7.1. Cyclotrons
11.7.2. Nuclear Reactors
11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2024 - 2031
11.8.1. Hospitals
11.8.2. Diagnostic Imaging Centers
11.8.3. Ambulatory Surgical Centers
11.8.4. Cancer Research Institute
11.9. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Bayer AG
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Bracco Imaging S.p.A.
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. Cardinal Health, Inc.
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Eli Lilly and Company (Eli Lilly)
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Curium Pharma
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. Lantheus Holdings, Inc.
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Novartis AG
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. Nordion (Canada) Inc.
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Jubilant Radiopharma
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Others
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
